Retina Drug Co. Can't End Claims It Misled Investors
Biopharmaceutical company Ophthotech Corp. must face some, but not all, claims that it misled investors regarding clinical trial phases for a macular degeneration drug, a New York federal judge ruled Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article